Gsk Share Discussion Threads

[abdullla] 03/12/2019 14:13

Ditto TM :-))))))

[tradermichael] 03/12/2019 13:12

GBP 1.0 = USD 1.30

[tradermichael] 03/12/2019 13:11

Looking grim this week. I've seen this before; price savaged to shake out the weak. This, often ahead of some good news and a renewed buying frenzy...… ;0)

[arja] 02/12/2019 15:02

not helping and getting hit in USA and UK price mirrors it from about 11.30am Uk time

[quepassa] 02/12/2019 14:41

UBS REITERATE BUY today with unchanged PRICE TARGET of 1900p

[arja] 27/11/2019 16:57

tradermichael,
negative SOH ? I stand by what I said . Anyway , GSK edging up and hopefully will reach 1780 level again in next week which is of more importance .

[abdullla] 26/11/2019 18:52

Not only GSK all pharmas react similarly unless they have bad news.

[lippy4] 26/11/2019 16:50

amazing how this share price can change...

[tradermichael] 26/11/2019 09:00

arja 26 Nov '19 - 08:52 - 20295 of 20298

To that I would say you have negative sense of humour and a need to convert a commentary on current topics into something more sinister.

[abdullla] 25/11/2019 10:40

In the absence of any good news there is bound to be a sell of/profit taking.

[lippy4] 22/11/2019 10:17

tm so true..

[abdullla] 22/11/2019 09:24

He missed out the tax man -:))

[tradermichael] 22/11/2019 09:01

The award for best tax return ever goes to…
…a man from Evesham.

HMRC have returned a tax return to a man in Evesham after he ‘apparently217; answered one of the questions incorrectly.

In response to the question “do you have anyone dependent on you?” The man answered:
“2.1 million illegal immigrants, 1.1 million crack heads, 2.2 million unemployable Jeremy Kyle scroungers, 900,000 criminals in over 85 prisons, plus 650 idiots in Parliament, and the whole of the European commission.”
HMRC deemed this response as unacceptable.

To this, the man replied saying “who did I miss out?”

[tradermichael] 22/11/2019 08:18

Crossing_the_Rubicon
21 Nov '19 - 16:43 - 20287 of 20289

Good article (if but a slightly heavy read!) …. thanks!

[philanderer] 21/11/2019 23:54

FWIW

UBS upgrades to BUY with tp 1900p

[coxsmn] 21/11/2019 19:49

Questor : Labour victory would knock £385bn off London stocks

[crossing_the_rubicon] 21/11/2019 16:43

GSK’s growth is expected to be driven in part by its oncology portfolio, and specifically, two assets within that portfolio.

The company recently provided additional data on Zejula, which was somewhat mixed, but ultimately a slight positive, as the drug has some opportunities for share gains from Lynparza. Going forward, the company will explore additional line extensions for Zejula.

Additionally, belantamab mafodotin could be the first BCMA drug class to market in the lucrative multiple myeloma indication. GSK will provide pivotal phase 2 details at ASH in early December.



In case anyone interested.

[tradermichael] 21/11/2019 11:03

Target: To rebuild dividend cover: 1.25x to 1.5x FCF in order to return to dividend growth

[essentialinvestor] 18/11/2019 13:30

Hi MT, thanks for the reply. Under 16.75 might add a few, may not happen.

[tradermichael] 18/11/2019 08:38

EssentialInvestor, on your comment on free cash flow (14 Nov '19 - 15:40 - 20267 of 20284), it looks reasonable to me, with increases in Q3 and in the 9 months of 2019. So long as the dividend is payable, reasons to be cheerful!


Q3: Cash flow Net cash inflow from operating activities was £2,515 million (Q3 2018: £2,077 million) and free cash flow was £1,939 million (Q3 2018: £1,554 million). The increased free cash flow primarily reflected improved operating profits, a lower seasonal increase in trade receivables and inventory, and reduced dividend payments to non-controlling interests.

9 months (2019): Net cash inflow from operating activities was £4,567 million (2018: £4,302 million) and free cash flow was £2,474 million (2018: £2,375 million). The increase primarily reflected improved operating profits, a lower seasonal increase in trade receivables, lower contingent consideration payments and reduced dividend payments to non-controlling interests.

From GSK Q3 highlights

[alphorn] 17/11/2019 16:25

Always depends upon where profits are taxed. Double tax agreements are not going to disappear.

[spud] 17/11/2019 16:22

Along with all the other companies in the Marxists spotlight. spud

[xxxxxy] 17/11/2019 13:36

And GSK will LEAVE the UK